297 related articles for article (PubMed ID: 28644180)
21. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
[TBL] [Abstract][Full Text] [Related]
22. Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab.
Turner D; Griffiths AM; Veerman G; Johanns J; Damaraju L; Blank M; Hyams J
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1460-5. PubMed ID: 23672831
[TBL] [Abstract][Full Text] [Related]
23. Transmural Healing Is Associated with Improved Long-term Outcomes of Patients with Crohn's Disease.
Fernandes SR; Rodrigues RV; Bernardo S; Cortez-Pinto J; Rosa I; da Silva JP; Gonçalves AR; Valente A; Baldaia C; Santos PM; Correia L; Venâncio J; Campos P; Pereira AD; Velosa J
Inflamm Bowel Dis; 2017 Aug; 23(8):1403-1409. PubMed ID: 28498158
[TBL] [Abstract][Full Text] [Related]
24. Endoscopic and histologic response to cyclosporine in ulcerative colitis and their impact on disease outcome: A cohort study.
Fron C; Pierry C; Poullenot F; Chabrun E; Subtil C; Capdepont M; Zerbib F; Belleannée G; Laharie D
Dig Liver Dis; 2016 Jul; 48(7):734-9. PubMed ID: 27052254
[TBL] [Abstract][Full Text] [Related]
25. Vedolizumab Drug Level Correlation With Clinical Remission, Biomarker Normalization, and Mucosal Healing in Inflammatory Bowel Disease.
Al-Bawardy B; Ramos GP; Willrich MAV; Jenkins SM; Park SH; Aniwan S; Schoenoff SA; Bruining DH; Papadakis KA; Raffals L; Tremaine WJ; Loftus EV
Inflamm Bowel Dis; 2019 Feb; 25(3):580-586. PubMed ID: 30165638
[TBL] [Abstract][Full Text] [Related]
26. Mucosal Healing in Ulcerative Colitis--When Zero is Better.
Boal Carvalho P; Dias de Castro F; Rosa B; Moreira MJ; Cotter J
J Crohns Colitis; 2016 Jan; 10(1):20-5. PubMed ID: 26438714
[TBL] [Abstract][Full Text] [Related]
27. Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis.
Shah SC; Colombel JF; Sands BE; Narula N
Clin Gastroenterol Hepatol; 2016 Sep; 14(9):1245-1255.e8. PubMed ID: 26829025
[TBL] [Abstract][Full Text] [Related]
28. Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort Study.
Prieux-Klotz C; Nahon S; Amiot A; Sinayoko L; Galéano-Cassaz C; Chaussade S; Coriat R; Lahmek P; Abitbol V
Dig Dis Sci; 2017 Feb; 62(2):473-480. PubMed ID: 27853898
[TBL] [Abstract][Full Text] [Related]
29. Intestinal Barrier Healing Is Superior to Endoscopic and Histologic Remission for Predicting Major Adverse Outcomes in Inflammatory Bowel Disease: The Prospective ERIca Trial.
Rath T; Atreya R; Bodenschatz J; Uter W; Geppert CE; Vitali F; Fischer S; Waldner MJ; Colombel JF; Hartmann A; Neurath MF
Gastroenterology; 2023 Feb; 164(2):241-255. PubMed ID: 36279923
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
Vucelic B
Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751
[TBL] [Abstract][Full Text] [Related]
31. The use of sirolimus (rapamycin) in the management of refractory inflammatory bowel disease in children.
Mutalib M; Borrelli O; Blackstock S; Kiparissi F; Elawad M; Shah N; Lindley K
J Crohns Colitis; 2014 Dec; 8(12):1730-4. PubMed ID: 25240477
[TBL] [Abstract][Full Text] [Related]
32. Anti-tumor Necrosis Factor-alpha Exposure Impacts Vedolizumab Mucosal Healing Rates in Pediatric Inflammatory Bowel Disease.
Jossen J; Kiernan BD; Pittman N; Dubinsky MC
J Pediatr Gastroenterol Nutr; 2020 Mar; 70(3):304-309. PubMed ID: 31738290
[TBL] [Abstract][Full Text] [Related]
33. Raman spectroscopy accurately differentiates mucosal healing from non-healing and biochemical changes following biological therapy in inflammatory bowel disease.
Smith SCL; Banbury C; Zardo D; Cannatelli R; Nardone OM; Shivaji UN; Ghosh S; Oppenheimer PG; Iacucci M
PLoS One; 2021; 16(6):e0252210. PubMed ID: 34077453
[TBL] [Abstract][Full Text] [Related]
34. Application of clinical indexes in ulcerative colitis patients in regular follow-up visit: correlation with endoscopic 'mucosal healing' and implication for management. Preliminary results.
Pagnini C; Menasci F; Festa S; Rizzatti G; Corleto VD; Delle Fave MM; D'Ambra G; Di Giulio E; Delle Fave G
Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3674-81. PubMed ID: 26502857
[TBL] [Abstract][Full Text] [Related]
35. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
[TBL] [Abstract][Full Text] [Related]
36. Mucosal healing in ulcerative colitis: where do we stand?
Fiorino G; Cesarini M; Indriolo A; Malesci A
Curr Drug Targets; 2011 Sep; 12(10):1417-23. PubMed ID: 21466490
[TBL] [Abstract][Full Text] [Related]
37. Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD.
Molander P; Sipponen T; Kemppainen H; Jussila A; Blomster T; Koskela R; Nissinen M; Rautiainen H; Kuisma J; Kolho KL; Färkkilä M
J Crohns Colitis; 2013 Oct; 7(9):730-5. PubMed ID: 23182163
[TBL] [Abstract][Full Text] [Related]
38. Development and Validation of a Confocal Laser Endomicroscopy-Based Score for In Vivo Assessment of Mucosal Healing in Ulcerative Colitis Patients.
Hundorfean G; Chiriac MT; Mihai S; Hartmann A; Mudter J; Neurath MF
Inflamm Bowel Dis; 2017 Dec; 24(1):35-44. PubMed ID: 29272480
[TBL] [Abstract][Full Text] [Related]
39. Plasma intestinal fatty acid-binding protein fails to predict endoscopic disease activity in inflammatory bowel disease patients.
Bodelier AG; Pierik MJ; Lenaerts K; de Boer E; Olde Damink SW; Hameeteman WM; Masclee AA; Jonkers DM
Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):807-13. PubMed ID: 26919325
[TBL] [Abstract][Full Text] [Related]
40. Normalization of C-Reactive Protein Predicts Better Outcome in Patients With Crohn's Disease With Mucosal Healing and Deep Remission.
Lin X; Qiu Y; Feng R; Chen B; He Y; Zeng Z; Zhang S; Chen M; Mao R
Clin Transl Gastroenterol; 2020 Feb; 11(2):e00135. PubMed ID: 32463625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
